Sustained response following BTK inhibitors based treatment in HIV-related primary central nervous system lymphoma: case report

CONCLUSIONS: This report highlights the safety and effectiveness of BTK inhibitors, as well as lenalidomide and PD-1 inhibitor in HIV-related PCNSL patients. Both the new therapeutic approaches and a multidisciplinary team authentically contributed to improved survival outcome among HIV-positive PCNSL patients.PMID:37644480 | PMC:PMC10466696 | DOI:10.1186/s12981-023-00554-8
Source: AIDS Research and Therapy - Category: Infectious Diseases Authors: Source Type: research